Nadim J Ajami Selected Research

16S Ribosomal RNA

1/2021	Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?
1/2021	A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers.
1/2020	Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions.
1/2020	Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence.
1/2019	Dietary quality and the colonic mucosa-associated gut microbiome in humans.
1/2018	Lung tissue microbial profile in lung cancer is distinct from emphysema.
1/2018	The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis.
11/2017	Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study.
11/2017	Association of Maternal Gestational Weight Gain With the Infant Fecal Microbiota.
7/2017	Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadim J Ajami Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 02/2014
12	Infections 01/2021 - 02/2014
9	Bronchiolitis 01/2019 - 01/2016
6	Inflammation (Inflammations) 01/2022 - 01/2017
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2016
3	Malnutrition (Nutritional Deficiencies) 01/2022 - 10/2015
2	Melanoma (Melanoma, Malignant) 12/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2021
2	Rotavirus Infections 01/2020 - 11/2018
2	Diarrhea 01/2020 - 01/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019 - 01/2019
2	Carcinogenesis 01/2019 - 11/2017
2	Ulcerative Colitis 01/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 07/2017
2	Dysbiosis 01/2018 - 04/2016
2	Virus Diseases (Viral Diseases) 01/2017 - 02/2014
2	Metabolic Diseases (Metabolic Disease) 01/2016 - 06/2015
2	Communicable Diseases (Infectious Diseases) 10/2015 - 01/2015
1	Weight Loss (Weight Reduction) 01/2022
1	Anus Neoplasms (Anal Cancer) 01/2022
1	Glioma (Gliomas) 01/2022
1	Disease Progression 01/2021
1	Pathologic Complete Response 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Granuloma 01/2021
1	Vulvar Neoplasms (Vulvar Cancer) 01/2021
1	COVID-19 12/2020
1	Hemorrhage 10/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2020
1	Necrosis 01/2020
1	Leukemia 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Lewis Lung Carcinoma 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Gastritis 04/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Polyps 01/2019
1	Respiratory Syncytial Virus Infections 01/2019
1	Obstructive Sleep Apnea 11/2018
1	Hypertension (High Blood Pressure) 11/2018
1	Colitis 01/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

14	16S Ribosomal RNAIBA 01/2021 - 09/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2015
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2015
3	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	Insulin (Novolin)FDA Link 12/2019 - 01/2018
2	InterferonsIBA 01/2019 - 01/2017
2	CytokinesIBA 01/2019 - 07/2017
2	Acetates (Acetic Acid Esters)FDA Link 01/2019 - 11/2018
2	salicylhydroxamic acid (SHAM)IBA 11/2018 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2015
2	AntigensIBA 01/2017 - 10/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 01/2014
1	EndotoxinsIBA 01/2022
1	Bacterial DNAIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Dietary Fiber FDA Link 12/2021
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	IronIBA 10/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	MucinsIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	SugarsIBA 01/2020
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 04/2019
1	InflammasomesIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	villinIBA 01/2019
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2019
1	PPAR deltaIBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	25-hydroxyvitamin DIBA 12/2018
1	OligosaccharidesIBA 11/2018
1	Rotavirus VaccinesIBA 11/2018
1	Volatile Fatty AcidsIBA 11/2018
1	PrebioticsIBA 11/2018
1	Neomycin FDA LinkGeneric 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	OrnithineIBA 01/2018

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2016
4	Immunotherapy 12/2021 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2021 - 08/2015
3	Fecal Microbiota Transplantation 01/2021 - 01/2017
2	Remission Induction 01/2021 - 01/2020
2	Length of Stay 01/2018 - 09/2017
2	Critical Care (Surgical Intensive Care) 01/2018 - 09/2017
2	Enema (Enemas) 01/2018 - 01/2017
2	Induction Chemotherapy 01/2017 - 01/2016
1	Aftercare (After-Treatment) 01/2022
1	Oral Administration 01/2022
1	Radiotherapy 01/2021
1	Chemoradiotherapy 01/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2019